B cells engage in a fierce competition to latch onto the spike protein of the coronavirus, ensuring their survival and honing their skills over time. A groundbreaking study reveals that these cells continue to improve long after vaccination, with the best of the best taking residence in the bone marrow alongside other elite immune fighters. This ongoing training is crucial, especially as new variants of the virus emerge.
